Sodium–glucose linked transporter-2 inhibitors: potential for renoprotection beyond blood glucose lowering?
- 1 October 2014
- journal article
- review article
- Published by Elsevier BV in Kidney International
- Vol. 86 (4), 693-700
- https://doi.org/10.1038/ki.2013.451
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney diseaseDiabetes, Obesity and Metabolism, 2013
- Effects of SGLT2 Inhibition in Human Kidney Proximal Tubular Cells—Renoprotection in Diabetic Nephropathy?PLOS ONE, 2013
- Renal Transport of Uric Acid: Evolving Concepts and UncertaintiesAdvances in Chronic Kidney Disease, 2012
- Acute and chronic effects of SGLT2 blockade on glomerular and tubular function in the early diabetic ratAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2012
- Effect of a Reduction in Uric Acid on Renal Outcomes During Losartan Treatment: A Post Hoc Analysis of the Reduction of Endpoints in Non-Insulin-Dependent Diabetes Mellitus With the Angiotensin II Antagonist Losartan TrialHypertension, 2011
- Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family membersDiabetes Therapy, 2010
- Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular RiskClinical Journal of the American Society of Nephrology, 2010
- Uric Acid and Cardiovascular RiskNew England Journal of Medicine, 2008
- Tubuloglomerular feedback: mechanistic insights from gene-manipulated miceKidney International, 2008
- Phlorizin Prevents Glomerular Hyperfiltration but not Hypertrophy in Diabetic RatsExperimental Diabetes Research, 2008